These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Octreotide. Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003 [No Abstract] [Full Text] [Related]
4. [Editor's commentary: Clinical use of somatostatin]. Tulassay Z Orv Hetil; 2013 Sep; 154(39):1526. PubMed ID: 24058096 [No Abstract] [Full Text] [Related]
5. Octreotide (sandostatin, sandoz). Mac Connachie AM Intensive Crit Care Nurs; 1996 Apr; 12(2):120-1. PubMed ID: 8845623 [TBL] [Abstract][Full Text] [Related]
6. How to use octreotide for malignant bowel obstruction. Ripamonti C; Mercadante S J Support Oncol; 2004; 2(4):357-64. PubMed ID: 15357519 [No Abstract] [Full Text] [Related]
9. [A trial of the use of sandostatin in patients with chronic pancreatitis]. Loginov AS; Sadokov VM; Vinokurova LV; Chernoiarova OD; Astaf'eva OV; Nilova TV Ter Arkh; 1995; 67(7):60-2. PubMed ID: 7482309 [TBL] [Abstract][Full Text] [Related]
12. Octreotide-induced bradycardia. Herrington AM; George KW; Moulds CC Pharmacotherapy; 1998; 18(2):413-6. PubMed ID: 9545165 [TBL] [Abstract][Full Text] [Related]
13. [Effects of octreotide on gastric mucosal massive hemorrhage in patients with portal hypertensive gastropathy]. Le Q; Zhang J; Xu Q; Gao H Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):68. PubMed ID: 11856512 [No Abstract] [Full Text] [Related]
14. Established and potential therapeutic applications of octreotide in palliative care. Prommer EE Support Care Cancer; 2008 Oct; 16(10):1117-23. PubMed ID: 18256859 [TBL] [Abstract][Full Text] [Related]
15. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide]. Laczi F; Magony S; Julesz J Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861 [TBL] [Abstract][Full Text] [Related]
16. [Octreotide (Famsynthesis): new possibilities in gastroenterology]. Velichko MA; Vreshch VD Voen Med Zh; 2001 May; 322(5):44-5. PubMed ID: 11550331 [No Abstract] [Full Text] [Related]
18. Chronic octreotide therapy can induce pancreatic insufficiency: a common but under-recognized adverse effect. Saif MW; Larson H; Kaley K; Shaib W Expert Opin Drug Saf; 2010 Nov; 9(6):867-73. PubMed ID: 20662741 [TBL] [Abstract][Full Text] [Related]
19. The challenge of treating malignant bowel obstruction. J Support Oncol; 2006 Feb; 4(2):83-4. PubMed ID: 16499129 [No Abstract] [Full Text] [Related]
20. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment? Sari S; Baris Z; Dalgic B J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):454-7. PubMed ID: 20512058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]